Product NDC: | 39822-1055 |
Proprietary Name: | Amphotericin B |
Non Proprietary Name: | Amphotericin B |
Active Ingredient(s): | 50 mg/10mL & nbsp; Amphotericin B |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 39822-1055 |
Labeler Name: | X-GEN Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063206 |
Marketing Category: | ANDA |
Start Marketing Date: | 19920429 |
Package NDC: | 39822-1055-5 |
Package Description: | 10 mL in 1 VIAL (39822-1055-5) |
NDC Code | 39822-1055-5 |
Proprietary Name | Amphotericin B |
Package Description | 10 mL in 1 VIAL (39822-1055-5) |
Product NDC | 39822-1055 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amphotericin B |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19920429 |
Marketing Category Name | ANDA |
Labeler Name | X-GEN Pharmaceuticals, Inc. |
Substance Name | AMPHOTERICIN B |
Strength Number | 50 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Lipid-based Polyene Antifungal [EPC],Polyene Antifungal [EPC],Polyenes [Chemical/Ingredient] |